The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Utilization of immortalized B cells to identify SDCBP as a novel therapeutic target in ovarian carcinoma.
 
Katelyn Handley
Travel, Accommodations, Expenses - Johnson & Johnson
 
Sumit Mehta
No Relationships to Disclose
 
Alexandra Martin
No Relationships to Disclose
 
Subir Biswas
No Relationships to Disclose
 
Kamira Karen Maharaj
No Relationships to Disclose
 
Jessica A. Mine
No Relationships to Disclose
 
Carla Cortina
No Relationships to Disclose
 
Mate Nagy
No Relationships to Disclose
 
Kimberly Sprenger
No Relationships to Disclose
 
Gunjan Mandal
No Relationships to Disclose
 
Patrick Innamarato
No Relationships to Disclose
 
John Joseph Powers
No Relationships to Disclose
 
Carly M. Harro
No Relationships to Disclose
 
Ricardo A. Chaurio
No Relationships to Disclose
 
Carmen M. Anadon
No Relationships to Disclose
 
Javier Pinilla-Ibarz
Honoraria - Abbvie; AstraZeneca; Janssen; Novartis; Pharmacyclics; Takeda
Consulting or Advisory Role - Abbvie; Janssen; Novartis; Pharmacyclics
Speakers' Bureau - Abbvie; AstraZeneca; Pharmacyclics/Janssen; Takeda
Patents, Royalties, Other Intellectual Property - From a WT vaccine patent by Memorial Sloan Kettering Cancer Center
 
Mian M. Shahzad
No Relationships to Disclose
 
Idhaliz Flores
Leadership - Sur180 Therapeutics
Stock and Other Ownership Interests - Sur180 Therapeutics
Patents, Royalties, Other Intellectual Property - Ponce Medical School Foundation; Sur180 Therapeutics
 
Jose Conejo-Garcia
Stock and Other Ownership Interests - Allogene Therapeutics; Anixa Biosciences; Compass Therapeutics
Honoraria - Allogene Therapeutics; Anixa Biosciences
Consulting or Advisory Role - Allogene Therapeutics; Anixa Biosciences; Compass Therapeutics
Research Funding - Anixa Biosciences
Patents, Royalties, Other Intellectual Property - Anixa Biosciences; Compass Therapeutics